SolasCure enrols first patient in a next phase II clinical trial to advance Aurase Wound Gel
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of ...
Tag: Clinical Trial
Adding chemotherapy to radiotherapy does not improve outcomes for cervical cancer patients
Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following ...
Blood-brain barrier dysfunction and inflammation linked to Down syndrome Regression Disorder
A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children's Hospital Los Angeles, ...
Combination of RAS inhibition and immunotherapy provides breakthrough for pancreatic cancer
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic ...
Automated insulin delivery systems are safe and effective for older adults with type 1 diabetes
New research from Washington State University in collaboration with five other institutions suggests that automated insulin delivery (AID) systems are ...
Non-invasive 40Hz gamma stimulation could help fight Alzheimer’s
A decade after scientists in The Picower Institute for Learning and Memory at MIT first began testing whether sensory stimulation ...
The Future of CBD research, marketing, and regulation
In this interview, Professor Ted Dinan, Medical Director at Atlantia Clinical Trials, and Asa Waldstein, Principal at Supplement Advisory Group, ...
UCLA study finds no significant benefit of paxlovid for vaccinated older adults
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research. The study ...
Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
UVA receives $9.3 million NIH grant for ketamine seizure treatment trial
University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National ...